Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 17, 2013
Response to Dahele and Senan
David Ball, Richard Fisher, Bev McClure, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 27, 2018
Reply to M. Sorigue et al
Michael MacManus, Richard Fisher, Bev McClure, et al.
Head & Neck
|
February 21, 2008
N2-N3 neck nodal control without planned neck dissection for clinical/radiologic complete responders-results of Trans Tasman Radiation Oncology Group Study 98.02
June Corry, Lester Peters, Richard Fisher, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 8, 2010
Phase 1 study of tirapazamine in combination with radiation and weekly cisplatin in patients with locally advanced cervical cancer
Danny Rischin, Kailash Narayan, Amit M Oza, et al.
Investigational New Drugs
|
January 24, 2004
A novel combination of cisplatin, irinotecan, and capecitabine in patients with advanced cancer
Michael Jefford, Michael Michael, Mark A Rosenthal, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 6, 2007
Stage is not a reliable indicator of tumor volume in non-small cell lung cancer: a preliminary analysis of the Trans-Tasman Radiation Oncology Group 99-05 database
David L Ball, Richard Fisher, Bryan Burmeister, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 31, 2004
Tirapazamine, Cisplatin, and Radiation versus Fluorouracil, Cisplatin, and Radiation in patients with locally advanced head and neck cancer: a randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02)
Danny Rischin, Lester Peters, Richard Fisher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 6, 2018
Randomized Trial of Systemic Therapy After Involved-Field Radiotherapy in Patients With Early-Stage Follicular Lymphoma: TROG 99.03
Michael MacManus, Richard Fisher, Daniel Roos, et al.
Annals of Surgery
|
September 16, 2016
Acute Adverse Events and Postoperative Complications in a Randomized Trial of Preoperative Short-course Radiotherapy Versus Long-course Chemoradiotherapy for T3 Adenocarcinoma of the Rectum: Trans-Tasman Radiation Oncology Group Trial (TROG 01.04)
Nabila Ansari, Michael J Solomon, Richard J Fisher, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 16, 2016
The impact on health-related quality of life in the first 12 months: A randomised comparison of preoperative short-course radiation versus long-course chemoradiation for T3 rectal cancer (Trans-Tasman Radiation Oncology Group Trial 01.04)
Sue-Anne McLachlan, Richard J Fisher, John Zalcberg, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
October 17, 2013
Response to Dahele and Senan
David Ball, Richard Fisher, Bev McClure, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 27, 2018
Reply to M. Sorigue et al
Michael MacManus, Richard Fisher, Bev McClure, et al.
Head & Neck
|
February 21, 2008
N2-N3 neck nodal control without planned neck dissection for clinical/radiologic complete responders-results of Trans Tasman Radiation Oncology Group Study 98.02
June Corry, Lester Peters, Richard Fisher, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
July 8, 2010
Phase 1 study of tirapazamine in combination with radiation and weekly cisplatin in patients with locally advanced cervical cancer
Danny Rischin, Kailash Narayan, Amit M Oza, et al.
Investigational New Drugs
|
January 24, 2004
A novel combination of cisplatin, irinotecan, and capecitabine in patients with advanced cancer
Michael Jefford, Michael Michael, Mark A Rosenthal, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 6, 2007
Stage is not a reliable indicator of tumor volume in non-small cell lung cancer: a preliminary analysis of the Trans-Tasman Radiation Oncology Group 99-05 database
David L Ball, Richard Fisher, Bryan Burmeister, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 31, 2004
Tirapazamine, Cisplatin, and Radiation versus Fluorouracil, Cisplatin, and Radiation in patients with locally advanced head and neck cancer: a randomized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02)
Danny Rischin, Lester Peters, Richard Fisher, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 6, 2018
Randomized Trial of Systemic Therapy After Involved-Field Radiotherapy in Patients With Early-Stage Follicular Lymphoma: TROG 99.03
Michael MacManus, Richard Fisher, Daniel Roos, et al.
Annals of Surgery
|
September 16, 2016
Acute Adverse Events and Postoperative Complications in a Randomized Trial of Preoperative Short-course Radiotherapy Versus Long-course Chemoradiotherapy for T3 Adenocarcinoma of the Rectum: Trans-Tasman Radiation Oncology Group Trial (TROG 01.04)
Nabila Ansari, Michael J Solomon, Richard J Fisher, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 16, 2016
The impact on health-related quality of life in the first 12 months: A randomised comparison of preoperative short-course radiation versus long-course chemoradiation for T3 rectal cancer (Trans-Tasman Radiation Oncology Group Trial 01.04)
Sue-Anne McLachlan, Richard J Fisher, John Zalcberg, et al.
Page
of 2